Heather Dixon faced challenging market conditions during her first full year as CFO of Acadia Healthcare. Net income decreased 17.9% to $264 million in 2024, down from the prior year, though the 2023 figure included a $15.7 million loss related to legal settlements.

Market response to Acadia Healthcare’s 2024 financial performance proved unfavorable. The company’s share price declined approximately 25% following the release of fourth-quarter results and 2025 guidance. Investors reacted to near-term profitability pressures and conservative forward projections.

Several factors contributed to financial performance challenges during 2024. Startup costs increased substantially as Acadia Healthcare brought 776 new beds online during the year. Fourth-quarter performance specifically reflected elevated costs associated with ramping newly opened facilities.

A handful of underperforming facilities emerged as a concern during the fourth quarter. Dixon characterized this as a “Q4 phenomenon,” noting that these facilities operated at expected levels during the first three quarters before experiencing deterioration. “If you look at those facilities across the first three quarters, they were running at a they were certainly running where we would have expected them to be,” Dixon explained.

Heather Dixon addressed facility performance issues directly with investors and analysts. The company does not expect material improvement from underperforming facilities during 2025, requiring continued monitoring and potential operational interventions. Management indicated willingness to close facilities that cannot achieve acceptable performance levels.

Revenue per patient day growth moderated during 2024, reaching 1.7% in the fourth quarter compared to 3.6% in the third quarter. This moderation reflects pricing dynamics across payer categories and service mix changes. Dixon provided detailed analysis of rate trends during earnings discussions with investors.

Timing differences for supplemental payments created quarterly volatility in financial results. Acadia Healthcare received $7 million in out-of-period supplemental payments during the first quarter of 2024, creating a difficult comparison for 2025. Dixon emphasized that full-year guidance assumes supplemental payments will be relatively flat, though quarterly timing may vary.

Facility closures also impacted financial results. Acadia Healthcare closed or consolidated three facilities during 2024, though these represented relatively small volume contributions. An additional facility closure at the beginning of 2025 created approximately $5 million of quarterly impact.

Despite near-term challenges, Heather Dixon maintained confidence in Acadia Healthcare’s strategic direction. She emphasized that the company’s growth strategy remains sound and that current investments position the organization for improved financial performance in 2026 and beyond.

Dixon’s communication with investors stressed the temporary nature of current profitability pressures. “Just to step back a little and talk about [2026] and beyond, I think we’ll have some tailwinds that come through EBITDA,” Dixon stated during the J.P. Morgan Healthcare Conference. The anticipated tailwinds include benefits from bed ramping, declining startup costs, and improved operational efficiency.